Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 1Pharmathen SA
02 12care4
03 1AOP Health
04 3Accord healthcare
05 1Alkermes Contract Pharma Services
06 1Arrotex Pharmaceuticals
07 1Bristol Myers Squibb
08 2Central Procurement & Supplies Unit
09 1Ebb Medical
10 1Generic Health
11 1Health House Pharma Ltd T/As P&D Pharmaceuticals Ltd
12 2Intas Pharmaceuticals
13 1L Molteni & C Dei F.Lli Alitti Spa Operating Company
14 1Molteni Farmaceutici
15 1NANO DARU
16 3ORIFARM GROUP AS
17 1OrPha Swiss
18 1P & D Pharmaceuticals Limited
19 2POA Pharma
20 1Paranova Pharmaceuticals Ab
21 1Prohealth Limited
22 1Teva Pharmaceutical Industries
23 1Unimedic AB
01 1Extended Release Injectable Suspension
02 2FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
03 12Film Coated Tablet
04 1Film Coated Tablet
05 2Film-Coated Tablets
06 1Long Acting Injectable
07 1PR Tablet
08 8Tablet
09 2tablet
01 1Allowed
02 4Approved
03 2Authorised
04 1DISCN
05 9Deregistered
06 2Invalid
07 1RX
08 2Withdrawn
09 8Blank
01 1ARX-NALTREXONE
02 1Destoxican
03 1NALOREX
04 1NALTREXONE
05 1NALTREXONE ACCORD HEALTHCARE
06 1Nalorex
07 1Naltrexine
08 1Naltrexon Ebb
09 1Naltrexon Molteni
10 1Naltrexon Vitaflo
11 1Naltrexone 2Care4
12 1Naltrexone Accord
13 1Naltrexone Accord Healthcare
14 1Naltrexone GH
15 3Naltrexone Hydrochloride
16 2Naltrexone Poa Pharma
17 6Revia
18 1VIVITROL
19 4Blank
01 2Australia
02 1Greece
03 2India
04 1Iran
05 2Italy
06 6Malta
07 13Sweden
08 1Switzerland
09 2USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 380MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Naltrexone 2Care4
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 29/06/2016
Application Number : 20151124000019
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : NALTREXONE ACCORD HEALTHCARE
Dosage Form : Film-Coated Tablets
Dosage Strength : 50 mg
Packaging : 14 UNITS 50 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Naltrexone Accord
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 04/02/2016
Application Number : 20150611000044
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : VIVITROL
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 380MG/VIAL
Packaging :
Approval Date : 2006-04-13
Application Number : 21897
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Naltrexon Vitaflo
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 04/02/2005
Application Number : 20040607008829
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Revia
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 10/03/2000
Application Number : 20000310000336
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Naltrexon Ebb
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 29/06/2016
Application Number : 20160213000120
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : PR Tablet
Dosage Strength : 8MG; 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : NALOREX
Dosage Form : Film-Coated Tablets
Dosage Strength : 50 mg
Packaging : 14 UNITS 50 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Extended Release Injectable Suspension
Dosage Strength : 380Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Revia
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 09/06/2004
Application Number : 20040607007310
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Revia
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 12/05/2004
Application Number : 20040512000048
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Naltrexine
Dosage Form : Film Coated Tablet
Dosage Strength : 45.2mg
Packaging :
Approval Date : 22/04/2003
Application Number : 56109
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Naltrexone Poa Pharma
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 24/04/2018
Application Number : 20170802000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Naltrexone Poa Pharma
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 01/11/2012
Application Number : 20111008000016
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALTREXONE
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 380MG/VIAL
Packaging :
Approval Date : 2023-07-06
Application Number : 213195
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Revia
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 06/09/2002
Application Number : 20020906000366
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Naltrexon Molteni
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Approval Date : 07/05/2015
Application Number : 20131221000020
Regulatory Info : Approved
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
